OSX Stock Overview
A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Osteopore Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.037 |
| 52 Week High | AU$0.78 |
| 52 Week Low | AU$0.036 |
| Beta | 0.19 |
| 11 Month Change | -2.63% |
| 3 Month Change | -13.95% |
| 1 Year Change | -94.52% |
| 33 Year Change | -98.93% |
| 5 Year Change | -99.70% |
| Change since IPO | -99.66% |
Recent News & Updates
Shareholder Returns
| OSX | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -7.5% | 0.5% | 1.5% |
| 1Y | -94.5% | 14.2% | 17.2% |
Return vs Industry: OSX underperformed the Australian Medical Equipment industry which returned 14.2% over the past year.
Return vs Market: OSX underperformed the Australian Market which returned 17.2% over the past year.
Price Volatility
| OSX volatility | |
|---|---|
| OSX Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in AU Market | 17.3% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: OSX has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: OSX's weekly volatility has decreased from 63% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Yujing Lim | www.osteopore.com |
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally. The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.
Osteopore Limited Fundamentals Summary
| OSX fundamental statistics | |
|---|---|
| Market cap | AU$4.39m |
| Earnings (TTM) | -AU$3.51m |
| Revenue (TTM) | AU$2.70m |
1.6x
P/S Ratio-1.2x
P/E RatioIs OSX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OSX income statement (TTM) | |
|---|---|
| Revenue | AU$2.70m |
| Cost of Revenue | AU$444.65k |
| Gross Profit | AU$2.25m |
| Other Expenses | AU$5.76m |
| Earnings | -AU$3.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.03 |
| Gross Margin | 83.51% |
| Net Profit Margin | -130.20% |
| Debt/Equity Ratio | 59.8% |
How did OSX perform over the long term?
See historical performance and comparison